Company Filing History:
1 out of 552 
1 out of 359 
Years Active: 2019
Title: Nobutaka Hanagata: Pioneer of Immunostimulating Oligonucleotides
Introduction: Nobutaka Hanagata, based in Tsukuba, Japan, is an innovative inventor recognized for his contributions to the field of immunology. With a solitary patent to his name, he has made significant strides in the development of oligonucleotide complexes that enhance immune responses.
Latest Patents: Hanagata's patent, titled "Immunostimulating Oligonucleotide Complex," describes an efficacious immunostimulating oligonucleotide designed for industrial production. This invention boasts exceptional type-I interferon-inducing activity, regardless of its modification status. The linear double-stranded oligonucleotide consists of 10 to 100 base pairs, with each single-stranded component containing 2 to 20 phosphodiester-mediated cytosine-guanine (CpG) sequences. Notably, at least 90% of the internucleotide bonds within each single strand maintain phosphodiester linkage, showcasing the complexity and effectiveness of his design.
Career Highlights: Throughout his career, Hanagata has worked with reputable institutions, including the National Institute for Materials Science and Denka Company Limited. These experiences have allowed him to refine his research and innovation skills dramatically.
Collaborations: In his pursuit of advancements in immunology, Hanagata has collaborated with notable colleagues such as Hiroshi Otsuka and Takafumi Harada. These collaborations have fostered a productive exchange of ideas and research, contributing to the success of his projects.
Conclusion: Nobutaka Hanagata stands out as a distinguished inventor in the field of immunology. His patent on immunostimulating oligonucleotides demonstrates his commitment to innovation and the potential for improving immune responses. As research continues to evolve, Hanagata's contributions will undoubtedly play a crucial role in the advancement of medical science.